ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 421941 | Rec_0434599 | Chromogranin-A-derived peptide |
SRMDQLAKELTAE |
Rattus norvegicus [Animal] |
- |
- |
- | LC-Orbitrap MS/MS |
29518334 | - |
YES |
| 421942 | Rec_0434600 | Chromogranin-A-derived peptide (M3 oxidation) |
SRMDQLAKELTAE |
Rattus norvegicus [Animal] |
- |
- |
- | LC-Orbitrap MS/MS |
29518334 | - |
YES |
| 421943 | Rec_0434601 | Unnamed |
YVNDAATLLPR |
Katsuwonus pelamis [Animal] |
- |
- |
- | LC-MS/MS |
- | - |
YES |
| 421944 | Rec_0434602 | Proenkephalin-A-derived peptide |
GGFMRF |
Rattus norvegicus [Animal] |
- |
- |
- | LC-Orbitrap MS/MS |
29518334 | - |
YES |
| 421945 | Rec_0434603 | PP1 |
TSSSLNMAVRGGLTR |
Eleusine coracana [Plant] |
- |
- |
- | MALDI-TOF MS/MS |
- | - |
YES |
| 421946 | Rec_0434604 | VYPGG (synthetic sample) |
VYPGG |
synthetic construct [Synthetic] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-converting enzyme (rabbit lung; Hip-HL substrate) |
197.1 μg/mL | IC50 (no enzyme pretreatment) |
- | - |
YES |
| 421947 | Rec_0434605 | VYPGG (synthetic sample) |
VYPGG |
synthetic construct [Synthetic] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-converting enzyme (rabbit lung; Hip-HL substrate) |
187.2 μg/mL | IC50 (pepsin pretreatment) |
- | - |
YES |
| 421948 | Rec_0434606 | VYPGG (synthetic sample) |
VYPGG |
synthetic construct [Synthetic] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-converting enzyme (rabbit lung; Hip-HL substrate) |
171.2 μg/mL | IC50 (chymotrypsin pretreatment) |
- | - |
YES |
| 421949 | Rec_0434607 | VYPGG (synthetic sample) |
VYPGG |
synthetic construct [Synthetic] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-converting enzyme (rabbit lung; Hip-HL substrate) |
169.1 μg/mL | IC50 (trypsin pretreatment) |
- | - |
YES |
| 421950 | Rec_0434608 | VYPGG (synthetic sample) |
VYPGG |
synthetic construct [Synthetic] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-converting enzyme (rabbit lung; Hip-HL substrate) |
170.7 μg/mL | IC50 (pepsin followed by chymotrypsin and trypsin pretreatment) |
- | - |
YES |
| 421951 | Rec_0434609 | GWA (synthetic) |
GWA |
synthetic construct [Synthetic] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-I converting enzyme |
98.92±5.73 μM | IC50 |
31398788 | - |
YES |
| 421952 | Rec_0434610 | AstC [pQ] |
QSRYRLCYFNPVSCF |
Hylobius abietis [Animal] |
- |
- |
- | MALDI-TOF/TOF MS/MS |
30165105 | - |
YES |
| 421953 | Rec_0434611 | TRP-1 |
VPSGFTGVR |
Hylobius abietis [Animal] |
- |
- |
- | Orbitrap MS/MS |
30165105 | - |
YES |
| 421954 | Rec_0434612 | Secretogranin-2-derived peptide (S6 phosphorylation) |
VPSPGSSEDDLQEEEQLEQAIKEHLGQGSSQEMEKLAK |
Rattus norvegicus [Animal] |
- |
- |
- | LC-Orbitrap MS/MS |
29518334 | - |
YES |
| 421955 | Rec_0434613 | Cerebellin-1-derived peptide |
GSAKVAFSAIRSTN |
Rattus norvegicus [Animal] |
- |
- |
- | LC-Orbitrap MS/MS |
29518334 | - |
YES |
| 421956 | Rec_0434614 | NPLP-2 |
SIGSLAKNGDLPYSY |
Hylobius abietis [Animal] |
- |
- |
- | MALDI-TOF/TOF MS/MS; Orbitrap MS/MS |
30165105 | - |
YES |
| 421957 | Rec_0434615 | tryptoPK (pyrokinin1 precursor product) |
FDAPNDRGPKEVSPMWFGPRI |
Hylobius abietis [Animal] |
- |
- |
- | MALDI-TOF/TOF MS/MS; Orbitrap MS/MS |
30165105 | - |
YES |
| 421958 | Rec_0434616 | Potide-J (synthetic linear) |
AVCENDLNCC |
synthetic construct [Synthetic] |
Antimicrobial, Antifungal |
Candida albicans |
- | Agar plate growth assay (qualitative) |
22605963 | - |
YES |
| 421959 | Rec_0434617 | Potide-J (synthetic Cys3-Cys9 disulfide) |
AVCENDLNCC |
synthetic construct [Synthetic] |
- |
Candida albicans |
- | Agar plate growth assay (qualitative) |
22605963 | - |
YES |
| 421960 | Rec_0434618 | Potide-J (synthetic Cys3-Cys10 disulfide) |
AVCENDLNCC |
synthetic construct [Synthetic] |
- |
Candida albicans |
- | Agar plate growth assay (qualitative) |
22605963 | - |
YES |